Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Reconstitution and Biomarkers in Newly Diagnosed Hodgkin Lymphoma Receiving Response-Adapted Therapy
NCT01858922Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Dec 2012
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ABVE-PC, dequalinium in Hodgkin lymphoma (HL), sponsored by Baylor College of Medicine. Started Dec 2012; status: completed.
02
Drugs
ABVE-PCdequalinium
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01858922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01858922.